Results 181 to 190 of about 17,995 (248)

Real-World Analysis of Healthcare Utilization, Treatment Patterns, and Economic Burden in Medicare Beneficiaries with Parkinson's Disease: Implications by Levodopa Formulation and Disease Severity. [PDF]

Pharmacoecon Open
Arnold RJG, Tse W, Martin K, Kuan R.
europepmc   +1 more source

Therapeutic effects of striatal dopaminergic modulation on idiopathic dystonia and OCD in humans: insights from the striosome hypothesis. [PDF]

Front Hum Neurosci
Matsumoto S, Shimazu H, Goto S.
europepmc   +1 more source

Complications and troubleshooting at the initial introduction of Levodopa-carbidopa continuous infusion gel therapy: A single-center study

, 2019
Yohei Mukai, Noriko Nishikawa, Yuji Takahashi, Miho Murata   +3 more
openalex   +2 more sources

The Identification and Challenges of Dopamine Dysregulation Syndrome: A Case Report. [PDF]

Cureus
Sulaiman A, Leppla I.
europepmc   +1 more source

Parkinson Disease in a Patient with Multiple Co-morbidities: A Delayed Diagnosis? [PDF]

, 2019
King, Theresa L.
core   +2 more sources

Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes

, 2014
Angelo Antonini, Ashley Yegin, Cornelia Preda, Lars Bergmann, Werner Poewe   +4 more
openalex   +2 more sources

PND23 COST-EFFECTIVENESS EVALUATION OF LEVODOPA/CARBIDOPA/ ENTACAPONE IN TREATMENT OF PARKINSON DISEASE

, 2010
R.I. Yagudinа, A.Yu. Kulikov, V.G. Serpik   +2 more
openalex   +1 more source

Parkinson disease treatments on national essential medicines lists, African Region. [PDF]

Bull World Health Organ
Fothergill-Misbah N, Cataldi R, Stothard M, Chowdhary N, Okubadejo N, Cappello B, Walker R, Dua T.   +7 more
europepmc   +1 more source

Sublingual Crushed Levodopa for Parkinson's Disease Management of a Lewy Body Dementia Patient With Dysphagia: A Case Report. [PDF]

Cureus
Regehr K, Yu J, Wu F, Shah R, Lau A.
europepmc   +1 more source

Bioequivalence of Foslevodopa/Foscarbidopa continuous subcutaneous infusion to arm, thigh, or flank versus abdomen in healthy and advanced Parkinson's disease individuals. [PDF]

Clin Park Relat Disord
Han YR, Jeong A, Ayub K, Gupta SV, Bergmann L, Kern DS, Pagan F, Rosebraugh M.   +7 more
europepmc   +1 more source